OS Therapies Incorporated
OSTX
$2.00
$0.189.89%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -104.23% | -45.58% | 37.83% | 21.01% | 42.61% |
| Total Depreciation and Amortization | -- | -100.00% | -12.50% | 600.00% | -100.00% |
| Total Amortization of Deferred Charges | -100.00% | -65.52% | -39.14% | -6.09% | -65.92% |
| Total Other Non-Cash Items | -- | -- | -- | -- | -100.00% |
| Change in Net Operating Assets | -17.57% | -843.77% | -80.07% | -65.33% | 845.77% |
| Cash from Operations | -172.57% | -286.13% | -6.03% | -49.86% | 42.80% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -100.00% | -100.00% | 84.62% | 9.81% | -39.80% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 835.33% | -164.10% | 9.87% | -44.18% |
| Cash from Financing | 576.66% | 510.39% | 66.81% | 15.09% | -45.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15,949.78% | 5,410.84% | 98.27% | -66.68% | -82.69% |